Table of Contents

1 Study Coverage

• 1.1 Histone Deacetylase 6 Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Histone Deacetylase 6 Market Size Growth Rate by Product
  • 1.4.2 Citarinostat
  • 1.4.3 CKD-504
  • 1.4.4 ACY-738
  • 1.4.5 HG-3001
  • 1.4.6 MPT-0B291
  • 1.4.7 Ricolinostat
  • 1.4.8 Others
• 1.5 Market by End User
  • 1.5.1 Global Histone Deacetylase 6 Market Size Growth Rate by End User
  • 1.5.2 CNS Lymphoma
  • 1.5.3 Colon Cancer
  • 1.5.4 Huntington Disease
  • 1.5.5 Inflammation
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Histone Deacetylase 6 Market Size
  • 2.1.1 Global Histone Deacetylase 6 Revenue 2014-2025
  • 2.1.2 Global Histone Deacetylase 6 Sales 2014-2025
• 2.2 Histone Deacetylase 6 Growth Rate by Regions
  • 2.2.1 Global Histone Deacetylase 6 Sales by Regions
  • 2.2.2 Global Histone Deacetylase 6 Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Histone Deacetylase 6 Sales by Manufacturers
  • 3.1.1 Histone Deacetylase 6 Sales by Manufacturers
  • 3.1.2 Histone Deacetylase 6 Sales Market Share by Manufacturers
  • 3.1.3 Global Histone Deacetylase 6 Market Concentration Ratio (CR5 and HHI)
• 3.2 Histone Deacetylase 6 Revenue by Manufacturers
  • 3.2.1 Histone Deacetylase 6 Revenue by Manufacturers (2014-2019)
  • 3.2.2 Histone Deacetylase 6 Revenue Share by Manufacturers (2014-2019)
• 3.3 Histone Deacetylase 6 Price by Manufacturers
• 3.4 Histone Deacetylase 6 Manufacturing Base Distribution, Product Types
  • 3.4.1 Histone Deacetylase 6 Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Histone Deacetylase 6 Product Type
  • 3.4.3 Date of International Manufacturers Enter into Histone Deacetylase 6 Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Histone Deacetylase 6 Sales by Product
• 4.2 Global Histone Deacetylase 6 Revenue by Product
• 4.3 Histone Deacetylase 6 Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Histone Deacetylase 6 Breakdown Data by End User

6 North America

• 6.1 North America Histone Deacetylase 6 by Countries
  • 6.1.1 North America Histone Deacetylase 6 Sales by Countries
  • 6.1.2 North America Histone Deacetylase 6 Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Histone Deacetylase 6 by Product
• 6.3 North America Histone Deacetylase 6 by End User

7 Europe

• 7.1 Europe Histone Deacetylase 6 by Countries
  • 7.1.1 Europe Histone Deacetylase 6 Sales by Countries
  • 7.1.2 Europe Histone Deacetylase 6 Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Histone Deacetylase 6 by Product
• 7.3 Europe Histone Deacetylase 6 by End User

8 Asia Pacific

• 8.1 Asia Pacific Histone Deacetylase 6 by Countries
  • 8.1.1 Asia Pacific Histone Deacetylase 6 Sales by Countries
  • 8.1.2 Asia Pacific Histone Deacetylase 6 Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Histone Deacetylase 6 by Product
• 8.3 Asia Pacific Histone Deacetylase 6 by End User

9 Central & South America

• 9.1 Central & South America Histone Deacetylase 6 by Countries
  • 9.1.1 Central & South America Histone Deacetylase 6 Sales by Countries
  • 9.1.2 Central & South America Histone Deacetylase 6 Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Histone Deacetylase 6 by Product
• 9.3 Central & South America Histone Deacetylase 6 by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Histone Deacetylase 6 by Countries
  • 10.1.1 Middle East and Africa Histone Deacetylase 6 Sales by Countries
  • 10.1.2 Middle East and Africa Histone Deacetylase 6 Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Histone Deacetylase 6 by Product
• 10.3 Middle East and Africa Histone Deacetylase 6 by End User

11 Company Profiles

• 11.1 Celgene Corp
  • 11.1.1 Celgene Corp Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Celgene Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Celgene Corp Histone Deacetylase 6 Products Offered
  • 11.1.5 Celgene Corp Recent Development
• 11.2 Chong Kun Dang Pharmaceutical Corp
  • 11.2.1 Chong Kun Dang Pharmaceutical Corp Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Products Offered
  • 11.2.5 Chong Kun Dang Pharmaceutical Corp Recent Development
• 11.3 Curis Inc
  • 11.3.1 Curis Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Curis Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Curis Inc Histone Deacetylase 6 Products Offered
  • 11.3.5 Curis Inc Recent Development
• 11.4 HitGen LTD
  • 11.4.1 HitGen LTD Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 HitGen LTD Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 HitGen LTD Histone Deacetylase 6 Products Offered
  • 11.4.5 HitGen LTD Recent Development
• 11.5 Kancera AB
  • 11.5.1 Kancera AB Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Kancera AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Kancera AB Histone Deacetylase 6 Products Offered
  • 11.5.5 Kancera AB Recent Development
• 11.6 Karus Therapeutics Ltd
  • 11.6.1 Karus Therapeutics Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Karus Therapeutics Ltd Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Karus Therapeutics Ltd Histone Deacetylase 6 Products Offered
  • 11.6.5 Karus Therapeutics Ltd Recent Development
• 11.7 Medivir AB
  • 11.7.1 Medivir AB Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Medivir AB Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Medivir AB Histone Deacetylase 6 Products Offered
  • 11.7.5 Medivir AB Recent Development
• 11.8 Merck & Co Inc
  • 11.8.1 Merck & Co Inc Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Merck & Co Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Merck & Co Inc Histone Deacetylase 6 Products Offered
  • 11.8.5 Merck & Co Inc Recent Development
• 11.9 Millennium Pharmaceuticals Inc
  • 11.9.1 Millennium Pharmaceuticals Inc Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Products Offered
  • 11.9.5 Millennium Pharmaceuticals Inc Recent Development
• 11.10 OnKure Inc
  • 11.10.1 OnKure Inc Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 OnKure Inc Histone Deacetylase 6 Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 OnKure Inc Histone Deacetylase 6 Products Offered
  • 11.10.5 OnKure Inc Recent Development
• 11.11 Quimatryx SL
• 11.12 Shuttle Pharmaceuticals LLC
• 11.13 Sigma-Tau SpA
• 11.14 SK Biopharmaceuticals Co Ltd

12 Future Forecast

• 12.1 Histone Deacetylase 6 Market Forecast by Regions
  • 12.1.1 Global Histone Deacetylase 6 Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Histone Deacetylase 6 Revenue Forecast by Regions 2019-2025
• 12.2 Histone Deacetylase 6 Market Forecast by Product
  • 12.2.1 Global Histone Deacetylase 6 Sales Forecast by Product 2019-2025
  • 12.2.2 Global Histone Deacetylase 6 Revenue Forecast by Product 2019-2025
• 12.3 Histone Deacetylase 6 Market Forecast by End User
• 12.4 North America Histone Deacetylase 6 Forecast
• 12.5 Europe Histone Deacetylase 6 Forecast
• 12.6 Asia Pacific Histone Deacetylase 6 Forecast
• 12.7 Central & South America Histone Deacetylase 6 Forecast
• 12.8 Middle East and Africa Histone Deacetylase 6 Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Histone Deacetylase 6 Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Histone Deacetylase 6 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Histone Deacetylase 6 market based on company, product type, end user and key regions.

This report studies the global market size of Histone Deacetylase 6 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Histone Deacetylase 6 in these regions.
This research report categorizes the global Histone Deacetylase 6 market by top players/brands, region, type and end user. This report also studies the global Histone Deacetylase 6 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Celgene Corp
Chong Kun Dang Pharmaceutical Corp
Curis Inc
HitGen LTD
Kancera AB
Karus Therapeutics Ltd
Medivir AB
Merck & Co Inc
Millennium Pharmaceuticals Inc
OnKure Inc
Quimatryx SL
Shuttle Pharmaceuticals LLC
Sigma-Tau SpA
SK Biopharmaceuticals Co Ltd

Market size by Product
Citarinostat
CKD-504
ACY-738
HG-3001
MPT-0B291
Ricolinostat
Others
Market size by End User
CNS Lymphoma
Colon Cancer
Huntington Disease
Inflammation
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Histone Deacetylase 6 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Histone Deacetylase 6 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Histone Deacetylase 6 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Histone Deacetylase 6 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Histone Deacetylase 6 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Histone Deacetylase 6 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.